Default company panoramic image

SEA Medical Systems, Inc.

SEA Medical is a health-tech company developing products that save lives and reduce cost in the hospital by preventing IV medication errors.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location San Jose, CA, USA
  • Currency USD
  • Founded October 2008
  • Employees 8
  • Website

Company Summary

Develop and manufacture proprietary products consisting of touch screen electronic devices, consumables containing sensor chips, recognition software, and drug libraries. IV medication errors can cause tragic consequences for patients in addition to adding non-reimbursable cost to the health care system. Customers include pharmacies, compounding pharmacies and supervised medical settings such as hospitals, chronic care facilities, and hospices.


  • Default avatar
    Michael Weickert

    Prior to S.E.A. Medical, Dr. Weickert was Chief Business Officer at Corium International, Inc. and StrataGent Life Sciences, Inc., and Senior Program Executive and Senior Director Product Marketing at Nektar Therapeutics.

    Prior to joining industry, Dr. Weickert researched gene regulation at the National Cancer Institute of NIH. He received his Ph.D. and M.S. in Genetics from the University of Wisconsin.

  • Default avatar
    Douglas Allen Hamilton

    Previously, he was a Partner at New Biology Ventures, CFO and COO at Javelin Pharmaceuticals, Director of Business Development at Paramount Capital Investments, CFO and Director of Business Development at PolarX Biopharmaceuticals and project manager at Pfizer and Amgen.

    Mr. Hamilton earned his honors BS in Medical Genetics from the University of Toronto and his MBA from the Richard Ivey School of Business at the University of Western Ontario

  • Default avatar
    Ravi Srinivasan
    Senior VP R&D

    Previously, he served as the member of executive management team and the board at Corium International following the acquisition of StrataGent Life Sciences, a company he cofounded. Dr. Srinivasan is also a cofounder of StemPar Sciences.

    Dr. Srinivasan received his Ph.D. from the Massachusetts Institute of Technology and B.Tech from the Indian Institute of Technonology in Mumbai.


  • Default avatar

Previous Investors

  • Default avatar
    J,K&B Capital
    Default avatar
    Quantum Technology Partners
    Default avatar
    New Biology Ventures, LLC